| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.32 | 0.02 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.34 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.29 | 0.04 |